Merck, Paratek antibiotic deal

Paratek (Boston, Mass.) granted MRK exclusive worldwide rights to develop and commercialize PTK 0796, an aminomethylcycline (AMC) antibiotic. An IV and an oral formulation of PTK 0796 are in Phase I t...